共 110 条
[1]
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[2]
Bray F(2006)The PD-1-PD-L pathway in immunological tolerance Trends Immunol 27 195-201
[3]
Siegel RL(2002)Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 793-800
[4]
Ferlay J(2002)Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Proc Natl Acad Sci U S A 99 12293-12297
[5]
Lortet-Tieulent J(2007)Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers Cancer Immunol Immunother 56 1173-1182
[6]
Jemal A(2009)Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma Clin Cancer Res 15 971-979
[7]
Okazaki T(2013)Clinical impact of programmed cell death ligand 1 expression in colorectal cancer Eur J Cancer 49 2233-2242
[8]
Honjo T(2013)The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer Breast Cancer Res Treat 139 667-676
[9]
Dong H(2007)Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer Proc Natl Acad USA 104 3360-3365
[10]
Strome SE(2016)PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer Gynecol Oncol 141 293-302